Curis, Inc. (CRIS)
Automate Your Wheel Strategy on CRIS
With Tiblio's Option Bot, you can configure your own wheel strategy including CRIS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CRIS
- Rev/Share 1.3188
- Book/Share -0.7779
- PB -3.0726
- Debt/Equity -0.3994
- CurrentRatio 1.2333
- ROIC -2.059
- MktCap 25004658.0
- FreeCF/Share -3.9538
- PFCF -0.7446
- PE -0.4819
- Debt/Assets 0.0671
- DivYield 0
- ROE 7.648
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | CRIS | H.C. Wainwright | -- | Buy | -- | $17 | May 19, 2025 |
News
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
LEXINGTON, Mass. , May 6, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved the grant of inducement stock options to its newly appointed Chief Medical Officer, Dr. Ahmed Hamdy to purchase 200,000 shares of Curis common stock, with a grant date of May 1, 2025 (the "Inducement Grant").
Read More
Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Curis, Inc. (NASDAQ:CRIS ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Diantha Duvall - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Ahmed Hamdy - Chief Medical Officer Jonathan Zung - Chief Development Officer Conference Call Participants Li Watsek - Cantor Fitzgerald Kripa Devarakonda - Truist Securities Operator Good morning ladies and gentlemen and welcome to the Curis Provides First Quarter 2025 Business Update Conference Call. At this time, all lines are in listen-only mode.
Read More
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Negative
Curis (CRIS) came out with a quarterly loss of $1.25 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to loss of $2.05 per share a year ago.
Read More
Curis Provides First Quarter 2025 Business Update
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
Curis strengthens executive team with the appointment of industry veteran Dr. Ahmed Hamdy as Chief Medical Officer Management to host conference call today at 8:30 a.m. ET LEXINGTON, Mass.
Read More
Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript
Published: March 31, 2025 by: Seeking Alpha
Sentiment: Neutral
Curis, Inc. (NASDAQ:CRIS ) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ET Company Participants Diantha Duvall - CFO Jim Dentzer - President and CEO Jonathan Zung - Chief Development Officer Conference Call Participants Sean McCutcheon - Raymond James Li Watsek - Cantor Fitzgerald Ed White - H.C. Wainwright Operator Good morning, and welcome to Curis's Fourth Quarter 2024 Business Update Call.
Read More
About Curis, Inc. (CRIS)
- IPO Date 2000-08-01
- Website https://www.curis.com
- Industry Biotechnology
- CEO Mr. James E. Dentzer
- Employees 34